Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consumer Drugs

Set Alert for Consumer Drugs

Nonprofit Pharma Targets Making Naloxone Available OTC, Trimming Price

Nonprofit Harm Reduction Therapeutics targets an OTC switch of naloxone, an opioid antagonist used to reverse an opioid overdose. It aims to make the product available at low cost in 110,000 retail locations nationwide.

Consumer Prescription To Otc Switch Drug Approval Standards

Latest From Consumer

More GRASE Time For 6 OTC Antiseptic Ingredients But 24 Flushed In Final Rule

An FDA final rule rejects generally regarded as safe and effective status for 24 OTC monograph antiseptic ingredients regarding products intended for use by health care professionals in hospitals or similar venues. However, six ingredients on which FDA deferred its decision also are used in consumer antiseptic washes, which GRASE decisions pending in separate rulemakings.

Consumer Drug Approval Standards

FDA Broadens Nicotine Therapy Indication Review With Steering Committee Docket

FDA seeks broader guidance than comments and information submitted at a January public hearing on standards testing and evaluations that could expand the variety of products approved as NRTs The docket is open to "recommend specific topics for direct, collective engagement and consideration by the" steering committee.

United States Consumer

Mucinex Fast-Max Advertising Claim Exceeds Indications In NAD Review

Review was second in two years by the Council of Better Business Bureaus' National Advertising Division of a challenge to Reckitt Benckiser ad claims for its Mucinex cough/cold line made by Procter & Gamble, which markets competing products including Vicks NyQuil and DayQuil brands.

Europe United Kingdom

P&G Extends Gum Repair Toothpaste Line As It Trims Production Footprint

P&G says harmful plaque bacteria below the gum line evades "even the most the diligent brushers." The firm plans in 2020 to move manufacturing of hair, oral and personal care products from Iowa to a facility in West Virginia.

United States US States

WaterPik Whitening Flosser Launch Adds Shine To Church & Dwight Results

Firm says it also looks to grow WaterPik sales with investment in international channels. Water Pik subsidiary says Whitening Water Flosser mixes a whitening agent with water, using its proprietary Whitening Infuser technology, and is sold with a 30-day supply of whitening tablets.

International United States

GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi

Firm's "power brands" in respiratory and pain areas achieved high single-digit sales growth in the fourth quarter on an “earlier and more severe” cold season that also drove overall consumer health sales in the period up 4.3% to $2.65bn.

Consumer Sales & Earnings
See All